Castro MO, Meléndez BJE, Pedro SIE, Mirabal FA, Rodríguez MA

Language: Spanish
References: 19
Page: 1238-1247
PDF size: 943.04 Kb.

ABSTRACT

A descriptive and cross-sectional study of 32 patients with priapism, assisted at the Urology Service of the "Saturnino Lora Torres" Provincial Teaching Clinical Surgical Hospital in Santiago de Cuba, was carried out from January, 2008 to December, 2014, in order to characterize them from the epidemiological, diagnostic and therapeutical points of view. The 20-29 age group and the black skin color predominated in the series, as well as and the idiopathic etiology as the most frequent one. In the 53.1% of the patients priapism type was not determined and 46.9% of them had more than 24 hours of clinical course before receiving medical assistance. Of those who arrived between 12-24 hours only 7.1% received surgical treatment. The medical treatment was not effective in 76.5% of the patients and 54.9% of them presented erectile dysfunction.

REFERENCES

1. Erección persistente o priapismo. [citado 15 Dic 2014].

2. Rodríguez Villalba R, García S, Puigvert Martínez A, María Pomerol I, Montseny J, Munárriz R. Priapismo. Actas Urol Esp. 2005 [citado 12 Nov 2014]; 29(10).

3. Rodríguez Villalba R, García S, Puigvert Martínez A, Pomerol Montseny JM, Munárriz R. Priapismo. Actas Urol Esp. 2005 [citado 15 Dic 2014]; 29(10).

4. Jiménez MM. El priapismo: una enfermedad de intenso dolor y potencialmente dañina. [citado 15 Dic 2014].

5. Broderick GA. Priapism. In: Wein AJ. Campbell-Walsh Urology. 10th ed. Philadelphia, Pa: Saunders Elsevier; 2011. p. 25.

6. Paladino N, Roldán D, Caram MS. Priapismo en pediatría: presentación inicial de una leucemia mieloide crónica. Arch argent pediatr. 2011 [citado 15 Dic 2014];109(5).

7. Eland IA, Van Der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. 2001; 57(5):970-2.

8. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001;13 suppl 5: S39-43.

9. Herreros Fernández ML, Pastor Gómez A, Gómez do Santos V, Barja Tur J, Díez García R, González Laguillo A. Priapismo: diagnóstico y tratamiento. An Pediatr. 2006;64 (5):489-91.

10. 10.Balparda-Arias Jk. Priapismo: concepciones clínicas, diagnósticas y de tratamiento. Gaceta Médica de Bilbao. 2010 [citado 15 Dic 2014]; 107(4).

11. Priapismo. [citado 16 Ene 2015].

12. Svarch E, Hernández Ramírez P, Ballester Santovenia JM. La drepanocitosis en Cuba. Rev Cubana Hematol Inmunol Hemoter. 2004 [citado 15 Dic 2014]; 20(2).

13. Agüero Hernández J. Priapismo. Rev Med Cos Cen. 2013 [citado 16 Ene 2015]; 70(607).

14. Ibanez Suarez R, Barranco Medina J, Flores Ortiz J, Arroyo Maestre JM, Querol Canteras A. Emergencias urológicas 2: Síndrome escrotal agudo. Priapismo. [citado 16 Ene 2015].

15. Winter CC, McDowell G. Experience with 105 patients with priapism: update review of all aspects. J Urol. 1988; 140(5):980-3.

16. Clemente Ramos LM. Priapismo. 2010 [citado 12 Nov 2014].

17. 17.Monkhouse SJ, Bell S. Low-flow priapism needs recognition and early correct treatment. Emerg Med J. 2007; 24(3):209-10.

18. 18.Broseta E, Judia A, Burgues JP, Luján S, Jiménez Cruz JF. Urgencias en Urología. Priapismo. En: Urología Práctica. 3 ed. España: Editorial Ene Ediciones; 2011. p. 36-8.

19. 19.Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010; 7;(Pt2):476-500.